Other Inpatient Care - APAC
APAC- The Other Inpatient Care market in APAC is anticipated to achieve a revenue of US$364.70bn by 2024.
- Looking ahead, it is expected to witness a compound annual growth rate (CAGR 2024-2028) of 3.37%, leading to a market volume of US$416.30bn by 2028.
- When compared globally, United States is projected to generate the highest revenue of US$349.40bn in 2024.
- In APAC, Japan's Other Inpatient Care market is witnessing a surge in demand due to the aging population and advanced healthcare infrastructure.
- Key regions:
- United States,
- China,
- India,
- Japan,
- Canada
Definition:
Other Inpatient Care refers to services that are not specifically mentioned in Inpatient Care, such as the inpatient services for infectious and parasitic diseases, endocrine, nutritional, and metabolic diseases, as well as mental and behavioral disorders, diseases of the nervous system, diseases of the respiratory system, diseases of the skin and subcutaneous tissue, diseases of the genitourinary system, certain conditions originating in the perinatal period, injury, poisoning, and conditions caused by external factors.
Additional information:
The Other Inpatient Care market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Inpatient care for infectious and parasitic diseases
- Inpatient care for endocrine, nutritional, and metabolic diseases
- Inpatient care for mental and behavioral disorders
- Inpatient care for diseases of the nervous system
- Inpatient care for diseases of the respiratory system
Out-Of-Scope
- Hospital day care
- Hospital long-term care
- Hospital outpatient care
- Hospital home-based care
